MyFinsight
Home
About
Contact
Back
Income Statement
ArriVent BioPharma, Inc. (AVBP)
source: myfinsight.com
Download
Download image
Total comprehensive
loss
-$31,400K
Net loss
-$31,399K
Total other
comprehensive gain (loss)
-$1K
Interest and investment
income
$2,224K
Operating loss
-$33,623K
Unrealized gain (loss) on
marketable securities
-$1K
Total operating
expenses
$33,623K
General and
administrative
$5,903K
Research and development
$27,720K
Back